| ID | Analyse | Domein | Recipiënt | Uitvoering | LTAT (uren (dagen)) | Accred. | LOINCeenheid (1) | LOINCeenheid (2) | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 4339 | Tryp.bruc. gambiense | Serum |
– | – | – | › | ||||
| 4340 | Trypanosoma cruzi | Serum |
1× per 2 weken | – | 57320-4 | – | › | |||
| 4341 | Trypanosoma evansi | Serum |
zelden, minder dan 1× per maand | – | – | – | › | |||
| 2413 | Trypsin-like imm. kat TLI (kat) | Serum |
1× per 2 weken | 470 (19,6) | – | – µg/l | – | › | ||
| 23401 | Tryptase | Serum |
2× per week, op maandag en donderdag | 157 (6,5) | – | 21582-2 µg/L | – | › | ||
| 24925 | TSH TSH | Serum |
maandag t/m vrijdag | 2 (0,1) | B | 3016-3 mU/L | – | › | ||
| 25360 | TSH-curve | Serum (4×) |
– | – | – | › | ||||
| 24946 | TSH (dier) TSH | Serum |
maandag t/m vrijdag | 4 (0,2) | – | – ng/mL | – | › | ||
| 24937 | TSI Anti-TSH-receptor antistoffen, Thyroid stimulating immuunglobuline, TRAB | Serum |
maandag t/m vrijdag | 4 (0,2) | B | 30567-2 IU/L | – | › | ||
| 57930 | TTCA g/creat. TTCA | Urine |
188 (7,8) | – | – | – | › | |||
| 6013 | Tuberculose QuantiferonTB IGRA, Interferon Gamma Release Assay, Quantiferon | Heparine (Lithium-heparinebuis) (2×) |
67 (2,8) | – | 71775-1 | – | › | |||
| 31203 | Tweede triage (12 maand) | ThinPrep (Cervix- / Vloeistofcytologie) |
241 (10) | – | – | – | › | |||
| 71048 | Ui f48 IgG | Serum |
2× per week, op dinsdag en vrijdag | – | – mgA/l | – | › | |||
| 75510 | Ureaplasma-Mycoplasma U Ureaplasma urealyticum - Mycoplasma hominis kultuur (urine) | Urine |
258 (10,8) | – | 43107-2 | – | › | |||
| 75515 | Ureaplasma-Mycoplasma SE Ureaplasma urealyticum - Mycoplasma hominis kultuur (semen) | Sperma (Semen) |
74 (3,1) | – | – | – | › | |||
| 75500 | Ureaplasma-Mycoplasma WC Ureaplasma urealyticum - Mycoplasma hominis kultuur (cervicaal) | eSwab |
67 (2,8) | – | – | – | › | |||
| 75505 | Ureaplasma-Mycoplasma WU Ureaplasma urealyticum - Mycoplasma hominis kultuur (urethraal) | eSwab |
113 (4,7) | – | – | – | › | |||
| 29645 | Ureaplasma-Mycoplasma WV | eSwab |
67 (2,8) | – | – | – | › | |||
| 29510 | Urethra cultuur Urethraal secreet kultuur | eSwab |
78 (3,3) | – | – | – | › | |||
| 21179 | Ureum | Serum |
maandag t/m vrijdag | 1 (0,1) | – | 3091-6 mg/dL | – mmol/L | › | ||
| 26880 | Ureum op 24 uur | 24-uurs urinecollectie |
71 (2,9) | – | 48999-7 | 25550-5 | › | |||
| 26885 | Ureum urine portie | Urine |
136 (5,7) | – | 3092-4 | 25998-6 | › | |||
| 29160 | Urinecultuur Urinekultuur, Urinekweek | Urine |
38 (1,6) | – | – | – | › | |||
| 26550 | Urinesediment (microsc.) Microscopisch onderzoek, Urinesediment | Urine |
4 (0,1) | – | – | – | › | |||
| 26568 | Urinestick | Urine |
5 (0,2) | – | – | – | › | |||
| 22186 | Urinezuur | Serum |
maandag t/m vrijdag | 2 (0,1) | B | 3084-1 mg/dL | – mmol/L | › | ||
| 28760 | Urinezuur | Gewrichtsvocht |
maandag t/m vrijdag | 3 (0,1) | – | 3085-8 mg/dL | – mmol/L | › | ||
| 26900 | Urinezuur op 24 uur | 24-uurs urinecollectie |
61 (2,5) | – | 14935-1 | – | › | |||
| 26905 | Urinezuur portie | Urine |
70 (2,9) | – | 25997-8 | – | › | |||
| 4445 | Ustekinumab Stelara | Serum |
1× per week | 185 (7,7) | – | 87408-1 µg/mL | – | › | ||
| 24453 | Vaccicheck kat/hond | Serum |
1× per week | 22 (0,9) | – | – | – | › | ||
| 29490 | Vagina cultuur Vaginaal secreet kultuur | eSwab |
62 (2,6) | – | – | – | › | |||
| 25912 | Valproaat Convulex, Depakine, Dipropylazijnzuur | Serum |
maandag t/m vrijdag | 2 (0,1) | B | 4086-5 mg/L | – umol/L | › | ||
| 57480 | Vanadium /g creatinine | Urine |
207 (8,6) | – | – | – | › | |||
| 5986 | Vancomycine | Serum |
maandag t/m zaterdag | – | 20578-1 µg/ml | – µmol/L | › | |||
| 24671 | Varicella zoster IgG | Serum |
maandag t/m zaterdag | 23 (1) | B | 8047-3 mIU/mL | – | › | ||
| 24670 | Varicella zoster IgM Herpes zoster IgM, VZV IgM | Serum |
maandag t/m zaterdag | 23 (1) | B | 5404-9 Index | – | › | ||
| 9791 | Varicella zoster PCR Herpes zoster | eSwab (Wissers varia / Overig) |
83 (3,4) | – | 11483-5 | – | › | |||
| 71026 | Varkensvlees f26 IgG | Serum |
2× per week, op dinsdag en vrijdag | – | – mgA/l | – | › | |||
| 96152 | VECTORSCREENING PCR HOND | EDTA |
406 (16,9) | – | – | – | › | |||
| 5623 | Vedolizumab | Serum |
1× per 1–2 weken | 332 (13,8) | – | – µg/mL | – | › | ||
| 22778 | VEGF Vascular Endothelial Growth Factor, VEGF, VEGF165 | Serum EDTA |
743 (31) | – | – | – | › | |||
| 5615 | Venlafaxine Efexor | Serum |
213 (8,9) | – | – | – | › | |||
| 28020 | Verdovende middelen Verdovende middelen in urine | Urine |
16 (0,7) | – | – | – | › | |||
| 52213 | verhouding | Heparine (Lithium-heparinebuis) |
282 (11,8) | – | – | – | › | |||
| 8440 | Verplichte DNA test VF | EDTA |
– | – | – | › | ||||
| 28340 | Vertering | Faeces |
67 (2,8) | – | 2605-4 | – | › | |||
| 58350 | Vetdosage Lipiden in faeces | Faeces 24-uurs faeces |
214 (8,9) | – | 16142-2 | – | › | |||
| 58360 | Vetten fractionatie | Faeces 24-uurs faeces |
– | – | – | › | ||||
| 52214 | Vetzurenprofiel EFA, Vetzuren in plasma, Vetzuurprofiel | Serum Heparine (Lithium-heparinebuis) |
315 (13,1) | – | – | – | › |
